Incidence of ERBB gene fusions (EGFR, ERBB2, ERBB4) across tumor types.

被引：1
|
作者：
Schubert, Laura
Elliott, Andrew
Doebele, Robert Charles
Lou, Emil
Borghaei, Hossein
Demeure, Michael J.
Kurzrock, Razelle
Le, Anh T.
Reuss, Joshua E.
Ou, Sai-Hong Ignatius
Braxton, David R.
Thomas, Christian A.
Darabi, Sourat
Korn, Wolfgang Michael
El-Deiry, Wafik S.
Liu, Stephen V.
机构：
[1] Univ Colorado, Sch Med, Denver, CO USA
[2] CARIS Life Sci, Irving, TX USA
[3] Rain Therapeut, Newark, CA USA
[4] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[5] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[6] Hoag Mem Hosp, Newport Beach, CA USA
[7] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[8] Georgetown Univ, Washington, DC USA
[9] Univ Calif Irvine, Orange, CA 92668 USA
[10] New England Canc Specialists, Scarborough, ME USA
[11] Caris Life Sci, Phoenix, AZ USA
[12] Brown Univ, Ctr Canc, Providence, RI 02912 USA
[13] Georgetown Univ, Sch Med, Dept Hematol & Oncol, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.3091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3091
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR, ERBB2 AND ERBB4 FUSIONS ARE RECURRENT ALTERATIONS IN MULTIPLE CANCER TYPES
    Schubert, L.
    Doebele, R. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (01) : 162 - 162
  • [2] Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum
    Ozaki, M
    Kishigami, S
    Yano, R
    NEUROSCIENCE RESEARCH, 1998, 30 (04) : 351 - 354
  • [3] Absence of EGFR, ERBB2 and ERBB4 mutation homologous to the oncogenic ERBB3 Val-104 mutation in colorectal cancers
    Choi, Mi R.
    Yoo, Nam J.
    Lee, Sug H.
    APMIS, 2015, 123 (01) : 87 - 88
  • [4] Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain
    Thompson, Mia
    Lauderdale, Simone
    Webster, Maree J.
    Chong, Victor Z.
    McClintock, Benjamin
    Saunders, Richard
    Weickert, Cynthia Shannon
    BRAIN RESEARCH, 2007, 1139 : 95 - 109
  • [5] Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities
    Penington, DJ
    Bryant, I
    Riese, DJ
    CELL GROWTH & DIFFERENTIATION, 2002, 13 (06): : 247 - 256
  • [6] NTAK, a novel member of the epidermal growth factor family that activates ErbB2, ErbB3 and ErbB4
    Nakano, N
    Higashiyama, S
    Ishiguro, H
    Nagatsu, T
    Taniguchi, N
    FASEB JOURNAL, 1998, 12 (08): : A1466 - A1466
  • [7] ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance
    Galanakis, I.
    Spyropoulos, E.
    Gkialas, I.
    Nomikos, A.
    Souka, E.
    Mitropoulos, D.
    JOURNAL OF BUON, 2013, 18 (03): : 653 - 659
  • [8] ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation
    Feroz, K
    Williams, E
    Riese, DJ
    CELLULAR SIGNALLING, 2002, 14 (09) : 793 - 798
  • [9] Somatic mutations of EGFR, ERBB2, ERBB3 and ERBB4 in juxtamembrane activating domains are rare in non-small cell lung cancers
    Park, Sang Wook
    Chung, Nak Gyun
    Han, Ji Youn
    Eom, Hyeon Seok
    Yoo, Nam Jin
    Lee, Sug Hyung
    APMIS, 2010, 118 (01) : 83 - 84
  • [10] Neuregulin receptors erbB2 and erbB4 in failing human myocardiumDepressed expression and attenuated activation
    S. Rohrbach
    B. Niemann
    R.-E. Silber
    J. Holtz
    Basic Research in Cardiology, 2005, 100 : 240 - 249
12345